Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000213763 | SCV000269241 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Thr110Thr in exon 2 of MITF: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 4.8% (205/4268) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs9849776). |
Gene |
RCV000839452 | SCV000981351 | benign | not provided | 2018-04-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000839452 | SCV001144509 | benign | not provided | 2018-11-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000213763 | SCV002550856 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316181 | SCV004015856 | benign | Melanoma, cutaneous malignant, susceptibility to, 8 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000839452 | SCV004564781 | benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000839452 | SCV005302317 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003917873 | SCV004728893 | benign | MITF-related disorder | 2019-03-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |